DK1156039T3 - Pyridazin-3-onderivater og mediciner, der indeholder samme - Google Patents
Pyridazin-3-onderivater og mediciner, der indeholder sammeInfo
- Publication number
- DK1156039T3 DK1156039T3 DK00905344T DK00905344T DK1156039T3 DK 1156039 T3 DK1156039 T3 DK 1156039T3 DK 00905344 T DK00905344 T DK 00905344T DK 00905344 T DK00905344 T DK 00905344T DK 1156039 T3 DK1156039 T3 DK 1156039T3
- Authority
- DK
- Denmark
- Prior art keywords
- group
- substituted
- unsubstituted
- medicines
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Fats And Perfumes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11049758A JP2000247959A (ja) | 1999-02-26 | 1999-02-26 | ピリダジン−3−オン誘導体及びこれを含有する医薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1156039T3 true DK1156039T3 (da) | 2006-01-30 |
Family
ID=12840099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00905344T DK1156039T3 (da) | 1999-02-26 | 2000-02-25 | Pyridazin-3-onderivater og mediciner, der indeholder samme |
Country Status (18)
Country | Link |
---|---|
US (1) | US6680316B1 (da) |
EP (1) | EP1156039B1 (da) |
JP (2) | JP2000247959A (da) |
KR (1) | KR100647726B1 (da) |
CN (1) | CN1148355C (da) |
AT (1) | ATE305926T1 (da) |
AU (1) | AU764393B2 (da) |
CA (1) | CA2364801C (da) |
DE (1) | DE60022986T2 (da) |
DK (1) | DK1156039T3 (da) |
ES (1) | ES2250100T3 (da) |
HK (1) | HK1044534B (da) |
HU (1) | HUP0200088A3 (da) |
NO (1) | NO319832B1 (da) |
NZ (1) | NZ513578A (da) |
RU (1) | RU2232755C2 (da) |
TW (1) | TWI249533B (da) |
WO (1) | WO2000050408A1 (da) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1142148C (zh) * | 1997-11-19 | 2004-03-17 | 兴和株式会社 | 新颖的哒嗪衍生物和含有其作为有效成分的药物 |
ATE425148T1 (de) * | 2000-09-18 | 2009-03-15 | Eisai R&D Man Co Ltd | Triazinone sowie deren medizinale anwendung |
AU761191B2 (en) * | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
KR20040039377A (ko) * | 2001-09-26 | 2004-05-10 | 코와 가부시키가이샤 | 수용성 페닐피리다진 유도체 및 이를 함유하는 의약 |
WO2004078751A1 (ja) * | 2003-03-07 | 2004-09-16 | Kowa Co., Ltd. | ベンゾフラン誘導体 |
CN1759103A (zh) * | 2003-03-18 | 2006-04-12 | 兴和株式会社 | 水溶性苯基哒嗪衍生物及含有该衍生物的医药品 |
EP1628665A2 (en) * | 2003-04-16 | 2006-03-01 | Amgen Inc. | 3-phenyl-4-(pyrimidin-2-yl)-6-(piperidin-4-yl) derivatives and related compounds as tnf-alpha and il-1 inhibitors for the treatment of inflammations |
WO2007044796A2 (en) * | 2005-10-11 | 2007-04-19 | Nps Pharmaceuticals, Inc. | Pyridazinone compounds as calcilytics |
JPWO2007049732A1 (ja) * | 2005-10-28 | 2009-04-30 | 興和株式会社 | 関節リウマチの予防及び/又は治療法 |
EP2953944B1 (en) * | 2013-02-07 | 2017-04-26 | Merck Patent GmbH | Pyridazinone-amides derivatives |
MX2017009624A (es) * | 2015-02-06 | 2017-11-20 | Merck Patent Gmbh | Macrociclos de piridazinona como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos. |
FR3103701B1 (fr) * | 2019-11-28 | 2021-11-26 | Inst Nat Sante Rech Med | Composés de typen2-arylméthyl-4-haloalkyl-pyridazin-3-one et leur utilisation |
UY39082A (es) * | 2020-02-14 | 2021-09-30 | Fmc Corp | Piridazinonas fungicidas |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2839532A (en) * | 1958-06-17 | Pyridazone compounds and process of | ||
GB788393A (en) * | 1953-04-30 | 1958-01-02 | Ciba Ltd | Process for the manufacture of pyridazone compounds |
US3840597A (en) | 1971-02-24 | 1974-10-08 | Riker Laboratories Inc | Substituted 2-phenoxy alkane-sulfonanilides |
AR206496A1 (es) | 1972-07-03 | 1976-07-30 | Riker Laboratories Inc | Procedimiento para la preparacion de 2-fenoxi-4-nitro-alquil o haloalquilsulfonanilidas |
US4238490A (en) * | 1979-02-12 | 1980-12-09 | Diamond Shamrock Corporation | Antihypertensive pyridazin(2H)-3-ones |
JPS57501328A (da) * | 1980-08-07 | 1982-07-29 | ||
US4545810A (en) | 1980-08-07 | 1985-10-08 | Sds Biotech Corporation | Herbicidal and plant growth regulant diphenylpyridazinones |
JPH0753725B2 (ja) | 1987-10-08 | 1995-06-07 | 富山化学工業株式会社 | 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤 |
FI91062C (fi) | 1988-12-28 | 1994-05-10 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisten naftaleenijohdannaisten valmistamiseksi |
MX9300141A (es) | 1992-01-13 | 1994-07-29 | Smithkline Beecham Corp | Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
DE69408598T2 (de) * | 1993-06-08 | 1998-09-17 | Vertex Pharmaceuticals Inc Cam | Pyridazine als Interleukin-1-beta Verwandlungsenzym Inhibitoren |
EP0871444A4 (en) | 1995-08-10 | 1999-01-13 | Merck & Co Inc | 2.5 SUBSTITUTED ARYL PYRROL, THE COMPOSITIONS THAT CONTAIN AND THE USE THEREOF |
CA2294548A1 (en) | 1997-08-22 | 1999-03-04 | Abbott Laboratories | Pyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors |
WO1999010331A1 (en) | 1997-08-22 | 1999-03-04 | Abbott Laboratories | Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors |
CN1142148C (zh) | 1997-11-19 | 2004-03-17 | 兴和株式会社 | 新颖的哒嗪衍生物和含有其作为有效成分的药物 |
TWI241295B (en) | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
CN1279026C (zh) | 1998-10-27 | 2006-10-11 | 艾博特公司 | 前列腺素内过氧化物h合酶生物合成抑制剂 |
-
1999
- 1999-02-26 JP JP11049758A patent/JP2000247959A/ja active Pending
-
2000
- 2000-02-25 AT AT00905344T patent/ATE305926T1/de not_active IP Right Cessation
- 2000-02-25 DE DE60022986T patent/DE60022986T2/de not_active Expired - Lifetime
- 2000-02-25 US US09/926,040 patent/US6680316B1/en not_active Expired - Fee Related
- 2000-02-25 TW TW089103388A patent/TWI249533B/zh not_active IP Right Cessation
- 2000-02-25 RU RU2001126063/04A patent/RU2232755C2/ru active
- 2000-02-25 DK DK00905344T patent/DK1156039T3/da active
- 2000-02-25 AU AU26928/00A patent/AU764393B2/en not_active Ceased
- 2000-02-25 NZ NZ513578A patent/NZ513578A/en not_active Application Discontinuation
- 2000-02-25 JP JP2000600991A patent/JP4456765B2/ja not_active Expired - Fee Related
- 2000-02-25 HU HU0200088A patent/HUP0200088A3/hu unknown
- 2000-02-25 CA CA002364801A patent/CA2364801C/en not_active Expired - Fee Related
- 2000-02-25 WO PCT/JP2000/001098 patent/WO2000050408A1/ja active IP Right Grant
- 2000-02-25 KR KR1020017009829A patent/KR100647726B1/ko not_active IP Right Cessation
- 2000-02-25 CN CNB00804242XA patent/CN1148355C/zh not_active Expired - Fee Related
- 2000-02-25 EP EP00905344A patent/EP1156039B1/en not_active Expired - Lifetime
- 2000-02-25 ES ES00905344T patent/ES2250100T3/es not_active Expired - Lifetime
-
2001
- 2001-08-23 NO NO20014099A patent/NO319832B1/no not_active IP Right Cessation
-
2002
- 2002-08-20 HK HK02106060.0A patent/HK1044534B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2364801C (en) | 2009-05-19 |
NO20014099D0 (no) | 2001-08-23 |
AU764393B2 (en) | 2003-08-14 |
TWI249533B (en) | 2006-02-21 |
NZ513578A (en) | 2005-04-29 |
HK1044534A1 (en) | 2002-10-25 |
WO2000050408A1 (fr) | 2000-08-31 |
NO20014099L (no) | 2001-10-23 |
US6680316B1 (en) | 2004-01-20 |
HUP0200088A2 (hu) | 2002-11-28 |
DE60022986T2 (de) | 2006-05-11 |
CA2364801A1 (en) | 2000-08-31 |
ES2250100T3 (es) | 2006-04-16 |
EP1156039B1 (en) | 2005-10-05 |
DE60022986D1 (de) | 2006-02-16 |
JP2000247959A (ja) | 2000-09-12 |
CN1148355C (zh) | 2004-05-05 |
CN1341103A (zh) | 2002-03-20 |
KR100647726B1 (ko) | 2006-11-23 |
HUP0200088A3 (en) | 2002-12-28 |
EP1156039A4 (en) | 2002-04-17 |
NO319832B1 (no) | 2005-09-19 |
AU2692800A (en) | 2000-09-14 |
HK1044534B (zh) | 2004-12-10 |
ATE305926T1 (de) | 2005-10-15 |
RU2232755C2 (ru) | 2004-07-20 |
JP4456765B2 (ja) | 2010-04-28 |
EP1156039A1 (en) | 2001-11-21 |
KR20010101979A (ko) | 2001-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR987000261A (ko) | 벤즈아미드옥심 유도체, 그의 제법 및 농원예용 살균제 (Benzamidoxime Derivative, Proecss for Production Thereof,and Agrohorticultural Bactericide) | |
DK1156039T3 (da) | Pyridazin-3-onderivater og mediciner, der indeholder samme | |
DK490288A (da) | Substituerede thiazolidindionderivater | |
ATE193828T1 (de) | Hypoglykämische dihydrochalconderivate | |
ATE370735T1 (de) | Phenylpyridazinderivate und diese enthaltende arzneimittel | |
DE60118225D1 (de) | Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren | |
DK0976748T3 (da) | Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet | |
DE69935718D1 (de) | Antidiabetische medikamente | |
CA2011087A1 (en) | Use of trifluoromethylphenylazolylmethyloxiranes as crop protection agents | |
ATE150964T1 (de) | Restenosehemmer nach perkutaner koronarer arterioplastie | |
DE60117847D1 (de) | Farnesyltransferase hemmende, in der 4-stellung substituierte chinolin- und chinazolinderivate | |
IE821337L (en) | Mandelic acid derivatives and mandelonitriles. | |
DE69918695D1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
DE69937045D1 (de) | Cyclische amidderivate | |
EP1182192A4 (en) | 4-HYDROXYPIPERIDINE DERIVATIVES WITH ANTI-ARRHYTHMIC EFFECT | |
AU2318600A (en) | Chondrongenesis promotors and indolin-2-one derivatives | |
DE69612611T2 (de) | Triazin-derivate | |
KR970702848A (ko) | 아릴피페리딘 및 아릴피페라진 유도체 및 이를 함유하는 약제(Arylpiperidine and arylpiperazine derivatives and drugs containing the same) | |
PT1265891E (pt) | Novos derivados heterociclicos ou benzenicos do acido lipoico sua preparacao e sua aplicacao a titulo de medicamentos | |
RU94037965A (ru) | Производные бензоксазола в виде рацемата или отдельных энантиомеров и их фармацевтически приемлемые соли и фармацевтические композиции с ингибирующей биосинтез лейкотриенов активностью | |
BR0308935A (pt) | Inibidor de fosfodiesterase iv contendo derivado de piridilacrilamida | |
ATE121073T1 (de) | Herbizide acrylonitrilderivate. | |
IL92646A0 (en) | Imidazolyl and pyridyl derivatives of phenyl substituted 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them | |
DE60221250D1 (de) | Bis(5-aryl-2-pyridyl)derivate | |
DE69018741D1 (de) | Konjugierte gamma-Hydroxybutenolid-Derivate und sie als aktiver Wirkstoff enthaltende Mittel gegen Magengeschwüre. |